Fifth Third Bancorp
ANAB icon

Fifth Third Bancorp’s AnaptysBio ANAB Stock Holding History

Fifth Third Bancorp’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$405 Buy
+6
New +$364 ﹤0.01% 4251
2019
Q4 		– Sell
-61
Closed -$2K – 2205
2019
Q3 		$2K Buy
+61
New +$2.9K ﹤0.01% 2034

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fifth Third Bancorp's ANAB Position: Q2 2026 in Review

Fifth Third Bancorp opened a new position in AnaptysBio (ANAB) in Q2 2026: 6 shares worth $405. The stake represents ﹤0.01% of the portfolio and ranks #4251 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in ANAB as recently as Q3 2019.

Fifth Third Bancorp first reported a position in ANAB in Q3 2019 and has held it in 2 quarters since. The position peaked at $2K in Q3 2019. 214 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Fifth Third Bancorp held 6 shares of AnaptysBio worth $405 as of Q2 2026.
  • AnaptysBio was a new Fifth Third Bancorp position in Q2 2026.
  • AnaptysBio made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4251 holding.
  • Fifth Third Bancorp first reported a position in AnaptysBio in Q3 2019 and has held it in 2 quarters since.
  • Fifth Third Bancorp's AnaptysBio position peaked at $2K in Q3 2019.
  • 214 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.